发明名称 |
TREATMENT FOR RHEUMATOID ARTHRITIS |
摘要 |
The present invention provides anti-GM-CSF antibodies for use in the treatment of rheumatoid arthritis. Anti-GM-CSF antibodies, in particular MOR103, are administered to patients suffering from rheumatoid arthritis at dosages that are beneficial in a clinical setting. |
申请公布号 |
SG11201501595Y(A) |
申请公布日期 |
2015.05.28 |
申请号 |
SG11201501595Y |
申请日期 |
2013.09.19 |
申请人 |
MORPHOSYS AG |
发明人 |
HAERTLE, STEFAN;LECLAIR, STEPHANE;SHEBL, AMGAD;STEIDL, STEFAN |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|